Study Objectives: To assess the methodological quality of published systematic reviews (SRs) and meta-analyses (MAs) about the efficacy of oral appliances (OA) in the management of adult and pediatric sleep-disordered breathing (SDB). Methods: SRs/MAs that evaluated the efficacy of OA therapy on the treatment of SDB in human subjects of all age groups were sought. Multiple electronic databases were searched for articles published in any language from the database's inception until January 2016. Two reviewers independently selected and then assessed the methodological quality of the studies using the Assessment of Multiple Systematic Reviews (AMSTAR) measurement tool. Results: Thirteen reviews on adult SDB were included (2 SRs and 11 SRs with MAs). Of those, seven were medium quality and six were high quality. Only four reviews were included on pediatric SDB (3 SRs and 1 SR with MA). Three of these were of high quality and one was medium quality. The identified limitations in the included reviews were failing to reference the excluded studies or describe reasons for exclusion, lack of applying valid criteria to assess the quality of included studies, lack of publication bias assessment, and absence of conflicts of interest reporting. Conclusions: Overall, SRs/MAs on OA therapy for adult and pediatric SDB were conducted with acceptable methodological quality. High AMSTAR scores should not be extrapolated as a proxy of the methodological quality of the included evidence. There is a need for more primary studies and then that information can be used to be synthesized through SRs on pediatric SDB. Keywords: mandibular advancement device, sleep apnea syndrome, systematic review, treatment efficacy Citation: Al-Jewair TS, Gaffar BO, Flores-Mir C. Quality assessment of systematic reviews on the efficacy of oral appliance therapy for adult and pediatric sleep-disordered breathing. J Clin Sleep Med 2016;12(8):1175-1183.
I NTRO DUCTI O N
Loud snoring and obstructive sleep apnea (OSA) are common sleep-disordered breathing (SDB) conditions that can affect growing and nongrowing individuals. OSA is characterized by repetitive partial (hypopnea) or complete (apnea) upper airway obstructions lasting at least 10 sec and by snoring during sleep. 1 The prevalence in adults ranges from 9% to 24% for OSA and from 2% to 4% for OSA when daytime symptoms are considered.
2 SDB/OSA occurs in 1.2% to 5.8% of children and adolescents. 3, 4 Multiple factors had been identified in the etiology of SDB/ OSA. These included structural constrictions of the soft tissue space surrounding the oropharynx and nasopharynx and its lumen (i.e., hypertrophied tonsils and/or adenoids), 1 constrictions surrounding the nasal cavity, 5 neuromuscular abnormalities of the upper airway, 1 hyperdivergent craniofacial growth patterns, 6 genetic markers (i.e., tumor necrosis factor-alpha), 7 early life programming 8 (i.e., exposure to secondhand cigarette smoking and poor nutrition), and prenatal factors such as hormonal and physiological changes during gestation, 9 in addition to other factors.
Pediatric and adult OSA are serious disorders. Untreated OSA has been linked to cardiovascular disease and hypertension in adults. 10 As well, attention deficit hyperactivity
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Quality Assessment of Systematic Reviews on the Efficacy of Oral Appliance Therapy for Adult and Pediatric Sleep-Disordered Breathing 12 To date, the first line of treatment for children with existing disease and/or at high risk for OSA is tonsillectomy and/or adenoidectomy. Other treatments include weight loss, intranasal corticosteroids, and continuous positive airway pressure, 13 which has been found to limit craniofacial development. 6 Oral appliances (OAs) such as maxillary expanders and mandibular orthopedic appliances have also been suggested to improve SDB outcomes. 12 Treatments for adult SDB include both surgical and nonsurgical interventions. 1 Non-surgical interventions include one or
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more of the following: adopting a healthier lifestyle (i.e., losing weight, avoiding alcohol, and positional therapy), CPAP therapy, or OA therapy. 1 OA therapy has shown improved effectiveness along with a higher level of compliance compared to the gold standard CPAP therapy. The American Academy of Sleep Medicine has set OAs treatment management parameters. 14 When properly indicated, OAs act by repositioning the mandible with the suprahyoid and genioglossal muscles attachments and tongue forward and inferiorly. This anterior and inferior movement of the mandible reduces the gravitational effect of the tongue, and stretches the palatoglossal and palatopharyngeal arches. This increases the dimensions of the velopharyngeal airway, thus potentially improving upper airway patency and preventing obstruction. 1 There are different OA design modifications that may include tongue retaining, soft palate lifting, and acrylic-based mandibular advancing devices.
Reliable scientific evidence on safety and efficacy comes from systematic reviews (SRs) of high-quality randomized controlled trials (RCTs). Evidence from these reviews supports stronger evidence-based guidelines for best clinical practices. With the growing number of published SRs in the literature, careful assessment of their methodological quality becomes important since evidence from low methodological quality SRs with high risk of bias is questionable and in some cases invalid.
Many SRs have been published on the efficacy of OA therapy in adult SDB, but only few about pediatric SDB. 1, 15 Yet, variability exists in the methodological quality of these reviews, which affects the applicability of their results and the subsequent interpretation of these results by professionals. Many factors have been identified that contribute to this variability, including types of included studies, reporting transparency, and methods employed to combine available data.
For a life-threating condition, such as severe SDB forms (namely OSA), extra efforts should be undertaken to identify sound high quality evidence-based guidelines to guide best practice for the management of SDB. In an effort to assess the quality of published SRs on the efficacy of OAs in adult severe SDB (OSA), Johal et al. 16 evaluated eight reviews/clinical practice guidelines comparing OAs with different modalities including no treatment. They reported variable quality with only two of the SRs being of high quality. More studies were published since their last search in 2013 and no study has evaluated the quality of SRs about pediatric OSA. Therefore, the objective of this study was to assess the methodological quality of SRs on the efficacy of OA therapy in the management of pediatric and adult SDB.
M ETHO DS
The preferred reported items for systematic reviews and metaanalyses (PRISMA) criteria 17 were followed during the reporting of this methodological quality assessment study.
Study Inclusion/Exclusion
Studies considered for inclusion were SRs with or without meta-analyses (MAs) published in any language. Only reviews that used the term "systematic review" or "meta-analysis" in their titles or their methodologies clearly indicated that a systematic review had been undertaken were included. Narrative reviews in which only systematic literature searching methods were used were excluded. The reviews had to evaluate the efficacy or effectiveness of OA therapy in the treatment of SDB including OSA of all levels of severity in children and/or adults. All types of OAs were considered without restrictions. Reviews comparing OAs with other interventions were also considered for inclusion. Primary studies, descriptive reviews, case reports, case series, editorials, commentaries, Task Force reports, clinical guidelines, and practice parameters were all excluded.
Data Sources
Multiple electronic databases (PubMed, Ovid MEDLINE, EM-BASE, Evidence Based Medicine Reviews, Cumulative Index to Nursing & Allied Health (CINAHL), and ProQuest Digital Dissertation) were searched for articles published from the database inception until January 2016. In addition, the Health Technology Assessment database, the American Dental Association Center for Evidence-Based Dentistry (ADA-EBD) website, and the World Wide Web using Google Scholar were searched. Reference lists of retrieved articles were also crosschecked for potential articles that may have been missed. A combination of Keywords and medical subject headings (MeSH) were used based on the database (supplemental material).
Two independent reviewers (T.J. and B.G.) selected the studies independently. All titles and abstracts were reviewed to identify potential studies. Articles that fulfilled the inclusion criteria or had incomplete information at this stage underwent full-text review to carefully assess their eligibility. Data were then extracted using a customized data abstraction sheet. Any disagreement was resolved through discussion.
Methodological Quality Assessment
The same two reviewers independently assessed the methodological quality of the studies using the Assessment of Multiple Systematic Reviews (AMSTAR) measurement tool. 18 The validity and reliability of the AMSTAR has been established in previous studies. 19, 20 The AMSTAR 18 tool assesses 11 domains in systematic reviews of intervention: a priori design, study selection and data extraction in duplicate, comprehensive literature search (at least two electronic database literature sources and one supplementary source), search for reports regardless of their publication status (i.e., gray literature), list of included/excluded studies, presentation of the characteristics of the included studies, documentation of methodological quality assessment, wellsupported conclusions that are based on the quality of evidence included, appropriate methods to combine individual findings of the selected studies or if discussed reasons for not combining studies, assessment of the likelihood of publication bias, and documentation of conflicts of interest and sources of funding in both the systematic review and the included studies. The possible responses for each item are "yes", "no", "cannot answer", or "not applicable". One point was given for every "yes" response and no points if the other responses were selected. Total scores were then calculated with the maximum possible score being eleven. A systematic review was described as high quality if scored (9-11), medium or low quality if scored (5-8) and (< 4) respectively. Disagreement in scoring between investigators was discussed openly and when required, a third investigator was consulted (C.F.M).
R ESU LT S
A total of 387 studies were identified and assessed for inclusion. After exclusion on the title and abstract stages, 44 articles were retrieved for full review. Two further articles were identified through reference search of retrieved articles. Twentynine articles 13, were later excluded after full-text review for different reasons ( Table 1) . Therefore, only 17 articles met the inclusion criteria set for this study (Figure 1 ). Thirteen reviews were on adult OSA (2 SRs and 11 SRs with MAs), 1, [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] and four reviews were on pediatric OSA (3 SRs and 1 SR with MA). 12, 15, 61, 62 Key methodological and descriptive characteristics of the included reviews are presented in Tables 2 and 3.
All the included reviews were published between 2004 and 2016 and were in English language except for one review 57 in Chinese. The number of included studies in each review ranged from 1 to 71 studies with different study designs. As expected, RCTs was the most commonly sought and included study type.
The studies included in the adult OSA reviews had the OA groups compared to one or more of the following groups: placebo, CPAP, surgery, another OA of different design, or pretreatment and posttreatment with only one OA type. With respect to the pediatric OSA reviews, the comparison groups included no treatment, placebo, and pretreatment and posttreatment with only one OA type. Two reviews 12, 62 included studies on maxillary expansion with and without concurrent use of fixed orthodontic appliances. Another review 15 included five RCTs that assessed seven independent interventions with only one of those targeting OAs. Table 4 presents the results of the methodological quality assessment using the AMSTAR tool. Seven of the reviews on The total mean score for the adult OSA studies was 7.85 ± 1.72 and the scores ranged from 5 to 11. Lie et al. 56 had the highest quality among all the reviews (11/11) and Iftikhar et al.'s 58 review had the lowest (5/11). Of the reviews on pediatric OSA, three were of high quality 15, 61, 62 and one was medium quality 12 and the total mean score for the studies was 9 ± 1.41 and the range was 7 to 10. Kuhle et al. 15 and Carvalho et al. 61 both had the highest score, whereas Huynh et al. 12 had the lowest score.
The numbers and percentage scores for each response option on the 11 AMSTAR tool domains are presented in Table 5 . All reviews had focused questions and a priori designs. The assessment of publication status by searching gray literature sources was conducted in 84.6% of adult reviews and all pediatric reviews. More than 23% of adult reviews failed to include a list or reference the excluded studies, or provide reasons for exclusion. Approximately 85% and 75% of adult and pediatric reviews, respectively, used a valid tool or criteria to assess the quality of included studies. The tools used included one or combination of the following: the American Academy of Sleep Medicine Classification of Evidence, the GRADE approach, the "Risk of bias" tools described in Cochrane Handbook of systematic review of interventions, the Jadad scale, Criteria from Centre for Reviews and Dissemination Report No. 4, and the Schulz et al. tool for allocation concealment. None of the pediatric reviews documented conflicts of interest.
DISCUSSI ON
The aim of this SR was to assess the quality of SRs/MAs about the efficacy of OA in the treatment of adult and pediatric SDB. Twelve SRs with MAs and five without MAs were included. Those five SRs without MAs explained that different definitions of OSA treatment success and failure among included studies, varied methodologies, and insufficient evidence were the main reasons for not combining the results quantitatively.
Adult SDB
All reviews were of medium or high quality according to the AMSTAR criteria. A priori design and providing characteristics of included studies are the only two criteria fulfilled by all reviews. The search strategies were well showcased in most reviews. Two reviews, 53,54 however, did not report the search dates and four others 49, [58] [59] [60] did not search the gray literature. There was significant variability in the instruments used for quality assessment among the reviews. McDaid et al. 51 assessed bias and allocation concealment, but the results were not presented for each study. Hoekema et al. 1 examined the efficacy and comorbidity of OAs in the treatment of OSA. For the comorbidity outcomes, the quality of the included studies was assessed based on the general impressions of the investigators and not on valid criteria. Although the authors of all the reviews documented conflicts of interest, in only one review 56 did the authors declare conflicts of interest for the individual studies included within the review.
Meta-analyses were conducted in 11 reviews. Statistical methods were appropriately used to combine the individual studies in most of the reviews (84.6%) except for one. 57 In that review, 57 randomized trials with both parallel and crossover designs were combined in the MA without justification. Only five reviews (38.5%) either assessed publication bias using funnel plots 55, [58] [59] [60] or described reasons for not investigating it. 56 Five of the 11 MAs 51,56,58-60 conducted sensitivity analyses to assess the robustness of the results.
The effects of OAs on adult SDB were found to be comparable when high-and moderate-quality adult SRs/MAs were independently evaluated. The six reviews 50, 52, 55, 56, 59, 60 that were identified as having high quality (low risk of bias) found superior efficacy of OAs over controls/placebo/no treatment. These reviews supported a reduction in apnea-hypopnea index (AHI), minimum oxygen saturation level, blood pressure, and arousal index with OAs, in addition to improvement in health-related quality of life. Yet, when compared with CPAP therapy, OAs were of similar or lower efficacy. The other seven moderate quality reviews 1, 49, 51, 53, 54, 57, 58 (moderate risk of bias) reported similar superior efficacy of OAs compared to control/placebo/ no treatment. In these reviews, OAs reduced AHI/respiratory disturbance index, improved blood pressure, and were associated with greater patient compliance and satisfaction. Comparisons with CPAP therapy demonstrated similar or superior efficacy of CPAP. Patients however, preferred OAs to CPAP as reported in these SRs.
Most of the primary studies included within the selected SRs were RCTs; however, most of these SRs reported that the quality of the included studies was moderate or low. Blinding and allocation concealment were impossible in many individual studies due to the differences between the interventions (i.e., OA vs. CPAP). Also, intent-to-treat analyses were not conducted in many studies, which may have introduced bias. There seems to be a dire need for better RCTs about the use of OAs in patients with SDB. There is also a need for a standard definition of SDB/OSA treatment success. The definitions of treatment success used in most trials were varied including 50% reduction in AHI, final AHI of less than 5, 10, or 15, and improvement in subjective symptoms. Treatment success Table 4 -Quality assessment of included reviews using the AMSTAR criteria. Scoring choices are "Y": Yes, "N": No; "CA": Can't answer, and "NA": Not applicable. "Y" items received one point and the sum was calculated. Reviews were considered high quality if scored (9-11), medium or low if scored (5-8) and (< 5) respectively.
depends on the severity of the disease and the design and degree of mandibular forward repositioning of OAs among other factors. Therefore, the development of a standard objective definition of treatment success and a further understanding of the predictors of treatment success are warranted in future studies. The duration of follow-up also varied greatly between the trials. Trials of shorter duration might have exaggerated the treatment efficacy as compared to trials of longer durations. Long-term stability of the changes was not assessed.
Pediatric SDB
Very few reviews were identified and included in this study. In one, Carvalho et al. 61 reported findings from only one quasirandomized trial with high risk of bias. Only two of the four reviews (50%) assessed publication bias. 15, 61 Similar to studies on adults, none of the reviews reported conflicts of interest among the primary studies. The small number of reviews on pediatric OSA reflects lack of trials on the controversial effects of the different modalities to treat OSA or persistent OSA after adenoidectomy and/or tonsillectomy in children and adolescents. Due to the great heterogeneity of the studies, only one SR 12 conducted a MA. Even there, the applicability of a MA is questionable due to the methodological heterogeneity between the included studies. Future studies are warranted about this important subgroup that seems to behave differently than the adult subgroup. In addition, normal or altered craniofacial growth changes come into play in this subsample. The effect of treatment on growth and the subsequent prognosis/risk for OSA has to be considered. For example, orthodontic treatment modalities that involve restriction of maxillary growth may worsen disease prognosis.
When the outcomes of OA therapy were compared between high-(low risk of bias) and moderate-quality (moderate risk of bias) SRs, only one high-quality SR 58 reported significant improvement in AHI after OAs, but with no cure or normalization of AHI. However, the other two high-quality SRs 11, 57 and the one moderate-quality SR 12 all reported insufficient evidence of OAs efficacy due to limited number of studies. Therefore, evidence on the efficacy of OA therapy for pediatric OSA yielded similar conclusions irrespective of the degree of risk of bias (significant consistency among studies).
Limitations
Similar to PRISMA, which only assesses the quality of reporting in the SRs, and not the risk of bias among the included studies inside those SRs, high AMSTAR scores should not be extrapolated as a proxy for the methodological quality of the included evidence. There is a need for more primary studies and then SRs on pediatric SDB.
CONCLUSI ONS
SRs/MAs on the efficacy of OAs in the management of SDB/ OSA are in general terms of acceptable quality, but there is still room for improvement. SRs/MAs on both adult and pediatric SDB/OSA can be strengthened by assessing publication bias in the meta-analyses and by documenting conflict of interest of the primary studies included within the SRs/MAs. Overall, OAs showed superior efficacy to no treatment/controls in the management of adult SDB/OSA, but evidence is insufficient to support the efficacy of those appliances in pediatric SDB/OSA.
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